英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
Apremilast Impurity 20;Apremilast Impurity TTN |
阿普斯特雜質(zhì)03 |
1802246-60-1 |
詳細(xì)
|
Acetate Impurity |
中間體乙酸酯雜質(zhì) |
219718-02-2 |
詳細(xì)
|
[1,1'-Biphenyl]-4-propanoic acid, α-[[(1,1-dimethylethoxy)carbonyl]amino]-, ethyl ester, (αR)- |
中間體羧酸乙酯雜質(zhì) |
1848219-25-9 |
詳細(xì)
|
(S)-N-(2-(1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-1,3-dioxoisoindolin-5-yl)acetamide |
阿普斯特雜質(zhì)19 |
2201974-01-6 |
詳細(xì)
|
Apremilast |
阿普斯特雜質(zhì)26 |
1384967-20-7 |
詳細(xì)
|
1H-Isoindole-1,3(2H)-dione, 5-amino-2-[1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]- |
對(duì)氨基雜質(zhì) |
253168-81-9 |
詳細(xì)
|
1H-Isoindole-1,3(2H)-dione, 2-[1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-5-nitro- |
對(duì)硝基雜質(zhì) |
253168-80-8 |
詳細(xì)
|
Dimethyl Impurity |
二甲基雜質(zhì) |
1809089-51-7 |
詳細(xì)
|
Apremilast Impurity TNA |
阿普斯特雜質(zhì) 10 |
1809170-71-5 |
詳細(xì)
|
N-((4aR,7R,8R,8aS)-6,8-dihydroxy-2-phenylhexahydropyrano[3,2-d][1,3]dioxin-7-yl)butyramide |
|
15767-89-2 |
詳細(xì)
|
N-((3R,4R,5S,6R)-2,4,5-Trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)butyramide |
N-((3R,4R,5S,6R)-2,4,5-三羥基-6-(羥甲基)四氫-2H-吡喃-3-基)丁酰胺 |
5441-12-3 |
詳細(xì)
|
OWIZSBUSCSIZSA-SFHVURJKSA-N |
OWIZSBUSCSIZSA-SFHVURJKSA-N |
182192-86-5 |
詳細(xì)
|
tert-Butyl(S)-(1-([1,1'-biphenyl]-4-yl)-3-hydroxypropan-2-yl)carbamate |
1426129-50-1對(duì)映異構(gòu)體 |
153037-40-2 |
詳細(xì)
|
N,N'-bis-(2-Chloroethyl)urea |
雙氯乙基脲 |
2214-72-4 |
詳細(xì)
|
3-[(2-Chloroethyl)amino]-1-propanol Hydrochloride |
3-[(2-Chloroethyl)aMino]-1-propanol Hydrochloride |
40722-80-3 |
詳細(xì)
|
1-Propanol, 3-[(2-chloroethyl)amino]- |
3-((2-氯乙基)氨基)丙-1-醇 |
40722-99-4 |
詳細(xì)
|
DSPE |
1,2-二硬酯酰-SN-甘油-3-磷酰乙醇胺 |
1069-79-0 |
詳細(xì)
|
Isophosphamide |
異環(huán)磷酰胺 |
3778-73-2 |
詳細(xì)
|
Ifosfamide impurity F CRS |
(RS)-2-Chloro-3-(2-chloroethyl)-1,3,2-oxazaphosphinane 2-oxide |
40722-73-4 |
詳細(xì)
|
(3aR,4S,7R,7aS)-rel-3a,4,7,7a-Tetrahydro-4,7-epoxyisobenzofuran-1,3-dione |
EXO-3,6-環(huán)氧-1,2,3,6-四氫鄰苯二甲酸酐 |
6118-51-0 |
詳細(xì)
|
(S)-(+)-Benzyl glycidyl ether |
(S)-芐氧甲基環(huán)氧乙烷 |
16495-13-9 |
詳細(xì)
|
Glycidyl methacrylate |
甲基丙烯酸縮水甘油酯 |
106-91-2 |
詳細(xì)
|
3-Glycidyloxypropyl(dimethoxy)methylsilane |
3-[(2,3)-環(huán)氧丙氧]丙基甲基二甲氧基硅烷 |
65799-47-5 |
詳細(xì)
|
3-Methylquinoline-2-carbonitrile |
3-甲基2-氰基喹啉 |
19051-05-9 |
詳細(xì)
|
3-Methylquinoline-2-carboxylic acid |
3-甲基喹啉-2-羧酸 |
92513-28-5 |
詳細(xì)
|
Methyl 3-Methylquinoline-2-carboxylate |
3-甲基喹啉-2-甲酸甲酯 |
53821-46-8 |
詳細(xì)
|
Apremilast Impurity N |
阿普斯特雜質(zhì)28 |
1384439-79-5 |
詳細(xì)
|
Apremilast Impurity E |
阿普斯特雜質(zhì)19 |
2095036-40-9 |
詳細(xì)
|
(S)-N-(2-(1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)- 1,3-dioxoisoindolin-4-yl)formamide |
阿普斯特雜質(zhì)FA |
2077897-94-8 |
詳細(xì)
|
Benzoic acid, 4-bromo-2-(methylamino)-, methyl ester |
Benzoic acid, 4-bromo-2-(methylamino)-, methyl ester |
1367708-38-0 |
詳細(xì)
|
(S)-4-amino-2-(1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl) ethyl)isoindoline-1,3-dione |
阿普司特N-脫乙酰基 |
635705-72-5 |
詳細(xì)
|
Methyl5-bromo-2-(methylamino)benzoate |
5-溴-2-(甲基氨基)苯甲酸甲酯 |
33922-96-2 |
詳細(xì)
|
6-(Trifluoromethyl)benzo[b]thiophen-3-amine |
6-(TRIFLUOROMETHYL)BENZO[B]THIOPHEN-3-AMINE |
165108-01-0 |
詳細(xì)
|
7-Bromo-4-chloro-8-methylquinazoline |
7-BROMO-4-CHLORO-8-METHYLQUINAZOLINE |
1592956-60-9 |
詳細(xì)
|
4,7-Dihydroxycoumarin |
4,7-二羥基香豆素 |
1983-81-9 |
詳細(xì)
|
4,7-dichloro-1H-imidazo[4,5-d]pyridazine |
4,7-dichloro-1H-imidazo[4,5-d]pyridazine |
17998-43-5 |
詳細(xì)
|
5,6-dihydro-1H-imidazo[4,5-d]pyridazine-4,7-dione |
5,6-二氫-1H-咪唑并[4,5-D]噠嗪-4,7-二酮 |
6293-09-0 |
詳細(xì)
|
3-Glycidoxy propyl trimethoxy silane |
3-(2,3-環(huán)氧丙氧)丙基三甲氧基硅烷 |
2530-83-8 |
詳細(xì)
|
4-Bromo-5-methoxypicolinaldehyde |
4-溴-5-甲氧基吡啶醛 |
1289092-48-3 |
詳細(xì)
|
2-(3,4-Difluorophenyl)oxirane |
2-(3,4-二氟苯基)環(huán)氧乙烷 |
111991-13-0 |
詳細(xì)
|
ETA |
2,3-環(huán)氧丙基三甲基氯化銨 |
3033-77-0 |
詳細(xì)
|
2-Bromo-5-methoxybenzenethiol |
2-溴-5-甲氧基苯硫醇 |
13993-51-6 |
詳細(xì)
|
C-(1H-pyrazol-4-yl)methylamine |
4-(氨基甲基)吡唑 |
37599-59-0 |
詳細(xì)
|
2-Chloro-N-cyclopropylacetamide |
2-氯-N-環(huán)丙基乙酰胺 |
19047-31-5 |
詳細(xì)
|
Difluoromethyl 2-pyridyl sulfone |
二氟甲基 (2-吡啶基)砜 |
1219454-89-3 |
詳細(xì)
|
(4-Fluoro-3-methoxy-phenyl)-methyl-amine |
(4-Fluoro-3-methoxy-phenyl)-methyl-amine |
904321-01-3 |
詳細(xì)
|
2-Bromo-5-methylbenzenethiol |
2-溴-5-甲基苯硫醇 |
19693-10-8 |
詳細(xì)
|
Methyl3-aminothieno[2,3-b]pyridine-2-carboxylate |
3-氨基吡啶噻吩-2-羧酸甲酯 |
111042-89-8 |
詳細(xì)
|
1,2-Epoxy-4-vinylcyclohexane |
1,2-環(huán)氧-4-乙烯基環(huán)己烷 |
106-86-5 |
詳細(xì)
|
(2S,3S)-3-Boc-amino-1,2-epoxy-4-phenylbutane(AtazanavirImpurity) |
1-芐基-2,3-環(huán)氧正丙基-氨基甲酸叔丁酯 |
98737-29-2 |
詳細(xì)
|
DMPG |
1,2-十四酰磷脂酰甘油鈉鹽 |
67232-80-8 |
詳細(xì)
|
dspe-peg 2000 |
聚乙二醇單甲醚-2000-二十八烷基磷脂酰乙醇胺 |
147867-65-0 |
詳細(xì)
|
DSPC |
二硬脂酰磷脂酰膽堿 |
816-94-4 |
詳細(xì)
|
T-5224 |
T-5224 |
530141-72-1 |
詳細(xì)
|
Poziotinib (HM781-36B) |
波齊替尼 |
1092364-38-9 |
詳細(xì)
|
CK 1827452 |
4-[[2-氟-3-[N'-(6-甲基吡啶-3-基)脲基]苯基]甲基]哌嗪-1-羧酸甲酯 |
873697-71-3 |
詳細(xì)
|
Leniolisib |
LENIOLISIB |
1354690-24-6 |
詳細(xì)
|
FK866(APO866,Daporinad) |
FK866鹽酸鹽水合物 |
658084-64-1 |
詳細(xì)
|
2-Naphthalenol, 4-[4-(3,8-diazabicyclo[3.2.1]oct-3-yl)-5,8-dihydro-2-[[1-(4-morpholinylmethyl)cyclopropyl]methoxy]pyrido[3,4-d]pyrimidin-7(6H)-yl]-5-iodo- |
化合物 KRAS G12D INHIBITOR 16 |
2648221-12-7 |
詳細(xì)
|
Telavancin Hydrochloride |
鹽酸特拉萬星 |
560130-42-9 |
詳細(xì)
|
Quizartinib dihydrochloride |
鹽酸喹扎替尼 |
1132827-21-4 |
詳細(xì)
|
Ruxolitinib Phosphate |
魯索利替尼磷酸鹽 |
1092939-17-7 |
詳細(xì)
|
INCB-018424 |
Ruxolitinib free base |
941678-49-5 |
詳細(xì)
|
Hypericin |
金絲桃素 |
548-04-9 |
詳細(xì)
|
AC220 |
奎扎替尼 |
950769-58-1 |
詳細(xì)
|
Donanemab |
Donanemab (多奈單抗 ) |
1931944-80-7 |
詳細(xì)
|
Erdafitinib |
厄達(dá)替尼 |
1346242-81-6 |
詳細(xì)
|
BRD0639 |
化合物 BRD0639 |
2760881-74-9 |
詳細(xì)
|
Gefitinib-based PROTAC 3 |
Gefitinib-based PROTAC 3 |
2230821-27-7 |
詳細(xì)
|
RG120 |
艾伏尼布 |
1448347-49-6 |
詳細(xì)
|
KRASG12Dinhibitor13 |
化合物 KRAS G12D INHIBITOR 13 |
2648552-62-7 |
詳細(xì)
|
Methanone, [2-(1H-indol-3-yl)-1H-imidazol-5-yl](3,4,5-trimethoxyphenyl)- |
VERU-111 |
1332881-26-1 |
詳細(xì)
|
NTP-42 |
NTP-42 |
2055599-51-2 |
詳細(xì)
|
Pralsetinib |
拉西替尼 |
2097132-94-8 |
詳細(xì)
|
Lecanemab |
侖卡奈單抗 |
1260393-98-3 |
詳細(xì)
|
JNJ-7706621 |
JNJ-7706621 |
443797-96-4 |
詳細(xì)
|
Erythromycin Cyclocarbonate |
環(huán)酯紅霉素 |
55224-05-0 |
詳細(xì)
|
((2R,3S,4R,5R)-3,4-Dihydroxy-5-((Z)-4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl isobutyrate (Molnupiravir Impurity) |
((2R,3S,4R,5R)-3,4-二羥基-5-((Z)-4-(羥基亞氨基)-2-氧代-3,4-二氫嘧啶-1(2H)-基)四氫呋喃-2 -基)甲基異丁酸酯 (莫鈉皮拉韋雜質(zhì)) |
2492423-29-5 |
詳細(xì)
|
BI 1015550 |
BI-1015550 |
1423719-30-5 |
詳細(xì)
|
Trofinetide |
曲非肽奈 |
853400-76-7 |
詳細(xì)
|
SN-38 Glucuronide |
SN-38葡糖苷酸 |
121080-63-5 |
詳細(xì)
|
3-Phenanthrenebutanoicacid |
3-菲丁酸 |
13728-56-8 |
詳細(xì)
|
FMF-04-159-2 |
FMF-04-159-2 |
2364489-81-4 |
詳細(xì)
|
Brincidofovir |
BRINCIDOFOVIR |
444805-28-1 |
詳細(xì)
|
NSC5844 |
N,N'-雙(7-氯-4-喹啉)-1,2-乙二胺 |
140926-75-6 |
詳細(xì)
|
Poziotinib Hydrochloride |
波齊替尼鹽酸鹽 |
1429757-68-5 |
詳細(xì)
|
Pyridoxalisonicotinoylhydrazone |
PYRIDOXAL ISONICOTINOYL HYDRAZONE |
737-86-0 |
詳細(xì)
|
Tofersen |
TOFERSEN |
2088232-70-4 |
詳細(xì)
|
GRT6005 |
CEBRANOPADOL |
863513-91-1 |
詳細(xì)
|
KRAS G12D inhibitor 5 |
KRAS G12D INHIBITOR 5 |
2621928-53-6 |
詳細(xì)
|
Bulevirtide |
布爾韋肽 |
2012558-47-1 |
詳細(xì)
|
Benzene, 4-bromo-1-chloro-2-[[4-[2-(cyclopropyloxy)ethoxy]phenyl]methyl]- |
4-溴-1-氯-2-(4-(2-環(huán)丙氧基乙氧基)芐基)苯 |
1118567-45-5 |
詳細(xì)
|
dapagliflozin |
達(dá)格列凈 |
461432-26-8 |
詳細(xì)
|
Bexagliflozin |
貝沙格列凈 |
1118567-05-7 |
詳細(xì)
|
Hydroxychloroquine sulfate |
硫酸羥氯喹 |
747-36-4 |
詳細(xì)
|
1-benzhydrylazetidine-3-carbaldehyde |
1-二苯甲基氮雜環(huán)丁烷-3-甲醛 |
72351-37-2 |
詳細(xì)
|
Ethanol, 2-[[4-[(7-chloro-4-quinolinyl)amino]pentyl]ethylamino]-, 1-acetate |
羥氯喹雜質(zhì)7 |
47493-14-1 |
詳細(xì)
|
1-benzhydrylazetidin-3-yl methanesulfonate |
1-二苯甲基-3-甲烷磺酸氮雜環(huán)丁烷 |
33301-41-6 |
詳細(xì)
|
1,4-Pentanediamine, N4-(7-chloro-4-quinolinyl)-N1-ethyl- |
羥基氯喹EP雜質(zhì)D-d5二鹽酸 |
1476-52-4 |
詳細(xì)
|
1-benzhydryl-3-bromoazetidine |
1-二苯甲基-3-溴氮雜丁烷 |
36476-84-3 |
詳細(xì)
|